Vaxcyte, Inc. (NASDAQ:PCVX) Receives Average Recommendation of “Buy” from Brokerages

Shares of Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) have been assigned a consensus rating of “Buy” from the six ratings firms that are presently covering the firm, MarketBeat.com reports. Six investment analysts have rated the stock with a buy rating. The average twelve-month price target among brokerages that have updated their coverage on the […]

Leave a Reply

Your email address will not be published.

Previous post OPKO Health (NASDAQ:OPK) Stock Price Up 3.9% Following Insider Buying Activity
Next post Genuine Parts (NYSE:GPC) Receives Consensus Recommendation of “Hold” from Analysts